Ma H - Search Results

1

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.

Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. Anastassiadis T, et al. Among authors: ma h. Nat Biotechnol. 2011 Oct 30;29(11):1039-45. doi: 10.1038/nbt.2017. Nat Biotechnol. 2011. PMID: 22037377 Free PMC article.

2

A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an extracellular signal-regulated kinase (ERK) inhibitor.

Anastassiadis T, Duong-Ly KC, Deacon SW, Lafontant A, Ma H, Devarajan K, Dunbrack RL Jr, Wu J, Peterson JR. Anastassiadis T, et al. Among authors: ma h. J Biol Chem. 2013 Sep 27;288(39):28068-77. doi: 10.1074/jbc.M113.505032. Epub 2013 Aug 9. J Biol Chem. 2013. PMID: 23935097 Free PMC article.

3

Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases.

Duong-Ly KC, Devarajan K, Liang S, Horiuchi KY, Wang Y, Ma H, Peterson JR. Duong-Ly KC, et al. Among authors: ma h. Cell Rep. 2016 Feb 2;14(4):772-781. doi: 10.1016/j.celrep.2015.12.080. Epub 2016 Jan 14. Cell Rep. 2016. PMID: 26776524 Free PMC article.

4

Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.

Vijayan RS, He P, Modi V, Duong-Ly KC, Ma H, Peterson JR, Dunbrack RL Jr, Levy RM. Vijayan RS, et al. Among authors: ma h. J Med Chem. 2015 Jan 8;58(1):466-79. doi: 10.1021/jm501603h. Epub 2014 Dec 12. J Med Chem. 2015. PMID: 25478866 Free PMC article.

5

The challenge of selecting protein kinase assays for lead discovery optimization.

Ma H, Deacon S, Horiuchi K. Ma H, et al. Expert Opin Drug Discov. 2008 Jun;3(6):607-621. doi: 10.1517/17460441.3.6.607. Expert Opin Drug Discov. 2008. PMID: 19662101 Free PMC article.

6

Protein kinase profiling assays: a technology review.

Wang Y, Ma H. Wang Y, et al. Among authors: ma h. Drug Discov Today Technol. 2015 Nov;18:1-8. doi: 10.1016/j.ddtec.2015.10.007. Epub 2015 Oct 31. Drug Discov Today Technol. 2015. PMID: 26723886 Review.

7

High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.

Coussens NP, Kales SC, Henderson MJ, Lee OW, Horiuchi KY, Wang Y, Chen Q, Kuznetsova E, Wu J, Chakka S, Cheff DM, Cheng KC, Shinn P, Brimacombe KR, Shen M, Simeonov A, Lal-Nag M, Ma H, Jadhav A, Hall MD. Coussens NP, et al. Among authors: ma h. J Biol Chem. 2018 Aug 31;293(35):13750-13765. doi: 10.1074/jbc.RA118.004274. Epub 2018 Jun 26. J Biol Chem. 2018. PMID: 29945974 Free PMC article.

8

Development of multiple cell-based assays for the detection of histone H3 Lys27 trimethylation (H3K27me3).

Qian J, Lu L, Wu J, Ma H. Qian J, et al. Among authors: ma h. Assay Drug Dev Technol. 2013 Sep;11(7):449-56. doi: 10.1089/adt.2013.515. Epub 2013 Aug 30. Assay Drug Dev Technol. 2013. PMID: 23992119 Free PMC article.

9

Small-molecule inhibitors of acetyltransferase p300 identified by high-throughput screening are potent anticancer agents.

Yang H, Pinello CE, Luo J, Li D, Wang Y, Zhao LY, Jahn SC, Saldanha SA, Chase P, Planck J, Geary KR, Ma H, Law BK, Roush WR, Hodder P, Liao D. Yang H, et al. Among authors: ma h. Mol Cancer Ther. 2013 May;12(5):610-20. doi: 10.1158/1535-7163.MCT-12-0930. Epub 2013 Apr 26. Mol Cancer Ther. 2013. PMID: 23625935 Free PMC article.

10

Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors.

McDonnell ME, Bian H, Wrobel J, Smith GR, Liang S, Ma H, Reitz AB. McDonnell ME, et al. Among authors: ma h. Bioorg Med Chem Lett. 2014 Feb 15;24(4):1116-21. doi: 10.1016/j.bmcl.2014.01.001. Epub 2014 Jan 9. Bioorg Med Chem Lett. 2014. PMID: 24461299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,467 results

Search Page